MARUHO CO., LTD.
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Private
- Established
- 1918-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.maruho.co.jp
An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis
- First Posted Date
- 2022-01-31
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT05214794
- Locations
- π―π΅
The University of Tokyo Hospital, Tokyo, Japan
Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis
- First Posted Date
- 2018-09-28
- Last Posted Date
- 2019-05-01
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT03688971
- Locations
- π³π±
Centre for Human Drug Research, Leiden, Netherlands
Topical Ionic Contra-Viral Therapy in Actinic Keratosis
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2018-09-26
- Last Posted Date
- 2019-05-01
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT03684772
- Locations
- π³π±
Centre for Human Drug Research, Leiden, Netherlands
ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients
- First Posted Date
- 2017-11-07
- Last Posted Date
- 2019-03-20
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT03334240
- Locations
- π³π±
LUMC/Centre For Human Drug Research, Leiden, Netherlands
A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
- First Posted Date
- 2017-08-23
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 491
- Registration Number
- NCT03259620
- Locations
- πΊπΈ
Skin Care Research, Inc., Boca Raton, Florida, United States
πΊπΈInternational Dermatology Research, Inc., Miami, Florida, United States
πΊπΈThe University of Texas Health Science Center at Houston, Houston, Texas, United States
Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis
- First Posted Date
- 2017-03-27
- Last Posted Date
- 2017-12-27
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT03091426
- Locations
- π³π±
LUMC/Centre for Human Drug Research, Leiden, Netherlands
Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-03-07
- Last Posted Date
- 2017-05-22
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT03071679
- Locations
- π³π±
LUMC/Centre for Human Drug Research, Leiden, Netherlands
A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-11-23
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 484
- Registration Number
- NCT02971891
A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis
- First Posted Date
- 2016-11-22
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Maruho Co., Ltd.
- Registration Number
- NCT02970331
Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-07-29
- Last Posted Date
- 2017-03-31
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02849262
- Locations
- π³π±
LUMC/Centre for Human Drug Research, Leiden, Netherlands
Β© Copyright 2024. All Rights Reserved by MedPath